Related Experiment Video
Updated: Nov 28, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Difference in hypertension prevalence applying three childhood hypertension management guidelines in a national
1Department of Preventive Medicine, North Sichuan Medical College, Nanchong, Sichuan, China. 1577371399@qq.com.
Insights
The American Academy of Pediatrics (AAP) guideline identifies more children with hypertension than European Society of Hypertension (ESH) or Fourth Report guidelines. Careful selection of pediatric hypertension management guidelines is crucial.
Area of Science:
- Pediatrics
- Cardiology
- Public Health
Background:
- Recent updates to childhood hypertension management guidelines by the European Society of Hypertension (ESH) and American Academy of Pediatrics (AAP).
- The need to compare prevalence estimates derived from different guidelines in a national context.
Purpose of the Study:
- To compare the prevalence of pediatric hypertension using the updated AAP and ESH guidelines versus the Fourth Report criteria.
- To assess the impact of guideline selection on hypertension prevalence in Chinese children.
Main Methods:
- A 4.6-year follow-up cohort study of 4276 children from the China Health and Nutrition Study.
- Hypertension defined using AAP, ESH, and Fourth Report guidelines at baseline and follow-up.
- Statistical comparison using Mc Nemar's test to evaluate differences in prevalence.
Main Results:
- The AAP guideline identified significantly higher hypertension prevalence at baseline (8.3% vs. 5.0% for ESH/Fourth Report) and follow-up (14.5% vs. 5.0%/6.0%).
- Prevalence was also higher with AAP for children identified in at least one survey (21.0% vs. 9.4%/10.4%) and both surveys (1.8% vs. 0.5%/0.6%).
- Elevated blood pressure definitions yielded similar comparative results across guidelines.
Conclusions:
- The AAP guideline results in a substantially higher prevalence of pediatric hypertension compared to ESH and Fourth Report guidelines.
- Clinical practice and public health strategies require careful consideration and selection of appropriate childhood hypertension management guidelines.
Abstract:
The European Society of Hypertension (ESH) and American Academy of Pediatrics (AAP) recently updated their childhood hypertension management guidelines. We aimed to compare the hypertension prevalence determined using the two aforementioned guidelines and Fourth Report in a national cohort study. This 4.6-year follow-up study included 4276 children who had participated in the China Health and Nutrition Study. At baseline and during a follow-up survey, hypertension was defined using the three guidelines. We calculated the pediatric hypertension prevalence in at least one survey and in both surveys as the number of participants identified as hypertensive in at least one survey or in both surveys divided by 4276, respectively. Using Mc Nemar's test, we determined that the prevalence of pediatric hypertension differed significantly according to AAP vs. ESH guidelines and Fourth Report at the baseline (8.3% vs. 5.0% and 5.0%, respectively; reference, AAP; Ps < 0.001 for AAP vs. ESH guidelines and Fourth Report) and follow-up surveys (14.5% vs. 5.0% and 6.0%, respectively; reference, AAP; both Ps < 0.001), as well as among those detected with hypertension in at least one survey (21.0% vs. 9.4% and 10.4%, respectively; reference, AAP; both Ps < 0.001) and both surveys (1.8% vs. 0.5% and 0.6%, respectively; reference, AAP; both Ps < 0.001). We obtained similar results when using the three guidelines to define childhood elevated blood pressure. Our findings confirm the higher prevalence of pediatric hypertension using AAP guideline than those using ESH guideline and Fourth Report. Consequently, childhood hypertension management guidelines should be selected and used with caution.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension and Regulation of Blood Pressure
Factors affecting Blood pressure
Physiological Factors:

